Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Andrew C JohnsMike YangLai WeiMadison GroganDaniel SpakowiczSandipkumar H PatelMingjia LiMarium HusainKari L KendraGregory A OttersonAshley E RoskoBarbara L AndersenDavid P CarboneDwight H OwenCarolyn J PresleyPublished in: The oncologist (2023)
Most characteristics of special interest among older adults, include fall risk, weight loss, cognitive limitations, and hearing loss, were not associated with irAEs in our study. However, decreased life-space mobility and depression are potential risk factors for IO toxicity among older adults with advanced cancer. Interventions designed to evaluate and mitigate modifiable risk factors for treatment-related toxicity are needed, and the results of this study may be useful for guiding those efforts.